Nonprescription Drugs: Considerations Regarding a Behind-the-Counter Drug Class
http://www.gao.gov/new.items/d09245.pdf
Reviews arguments for and against the creation of a class of drugs that would be midway between over-the-counter status and prescription-only status, looks at drug availability in Australia, Italy, the Netherlands, the United Kingdom, and the U.S. since 1995, and the impact of restricted nonprescription status on drug availability. From the Government Accountability Office.
Comments
Comments are not allowed for this entry.
